3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
9
Breast Neoplasms
6
Neoplasms
4
Colorectal Neoplasms
3
Multiple Myeloma
2
Insulin Resistance
2
Cardiotoxicity
2
Weight Loss
1
Warts
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Fatigue
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Cachexia
1
Brenner Tumor
1
Bone Metastases
1
Body Weight
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Cyclosporins
2
Cyclosporine
2
Cyclophosphamide
2
Antilymphocyte Serum
2
Alemtuzumab
2
thymoglobulin
1
plerixafor
1
fosphenytoin
1
fludarabine
1
Thiotepa
1
Therapeutics
1
Tacrolimus
1
Phlebotomy
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Melphalan
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Busulfan
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunologic Deficiency Syndromes
×
Exercise
×
Clear all
No trials found.